NPCE · NeuroPace Inc
United States · RS rating 38 · As of 2026-11-03
| Price | 12.31 USD |
|---|---|
| 1-day change | -0.2% |
| RS rating (overall / 1M / 3M / 12M) | 38 / 41 / 46 / 71 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 30 / 18 / 35 |
| Industry group (rank) | Medical-Products (106) |
| EPS growth Q/Q | +27.3% |
| Sales growth Q/Q | -2.8% |
| Distance from 52-week high | +36.2% |
| Market cap (USD) | $572.7M |